FOXP3 Activators
Common FOXP3 Activators include, but are not limited to Rapamycin CAS 53123-88-9, Valproic acid sodium salt CAS 1069-66-5, Trichostatin A CAS 58880-19-6, Suberoylanilide Hydroxamic Acid CAS 149647-78-9 and Sodium Butyrate CAS 156-54-7.
FOXP3 Activators belong to a specialized chemical class that has garnered scientific interest for their ability to modulate the activity of the FOXP3 gene. FOXP3 encodes a crucial transcription factor that plays a central role in the regulation of immune responses and maintenance of immune homeostasis. FOXP3 is primarily expressed in regulatory T cells (Tregs), a subset of T cells known for their suppressive function in controlling immune reactions and preventing autoimmunity. Dysregulation of FOXP3 expression or function can lead to autoimmune disorders and immune-related diseases. FOXP3 Activators function by influencing the pathways and factors involved in FOXP3 gene expression, impacting the differentiation and function of regulatory T cells and overall immune balance.
Developing FOXP3 Activators requires an in-depth understanding of the regulatory elements within the FOXP3 gene, as well as the signaling pathways and transcription factors that control its expression. Researchers in this field aim to engineer molecules that promote the activation of FOXP3 gene expression, contributing to its role in mediating regulatory T cell function and immune suppression. These activators often employ innovative design strategies to enhance the binding of transcription factors to FOXP3 promoter regions, leading to increased FOXP3 expression and regulatory T cell activity. By unraveling the complexities of FOXP3-mediated immune regulation, researchers gain insights into its significance in fundamental biological phenomena and immune homeostasis. Ongoing advancements in molecular pharmacology and chemical synthesis drive the ongoing refinement of FOXP3 Activators, offering applications across various scientific domains where manipulation of immune responses and regulatory T cell function is of interest.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid is a well-known HDAC inhibitor that has been shown to enhance FOXP3 expression in CD4+ T cells. It can promote the differentiation of naive T cells into regulatory T cells by affecting the acetylation status of histones associated with the FOXP3 promoter region. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A (TSA) is a potent HDAC inhibitor that has been reported to increase FOXP3 expression in CD4+ T cells and promote the development of regulatory T cells. It affects the epigenetic landscape of the FOXP3 locus, leading to increased accessibility for transcription factors. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
SAHA, also known as Vorinostat, is an HDAC inhibitor researched for cancer therapy. It has been found to induce FOXP3 expression in CD4+ T cells and enhance the suppressive function of regulatory T cells. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Butyrate is a short-chain fatty acid produced by the gut microbiota during the fermentation of dietary fiber. It serves as an HDAC inhibitor and has been associated with increased FOXP3 expression in regulatory T cells, contributing to immune homeostasis in the gut. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat is another HDAC inhibitor that has shown potential in inducing FOXP3 expression and promoting the development of functional regulatory T cells. It has been explored in the context of immunotherapy. | ||||||